Johnson & Johnson Seeks FDA Approval for Caplyta in Bipolar Mania
Valid market news retained in the public archive without immediate LiveCast distribution.
Story updates
01:02:10 PM UTC
SquawkNews
JOHNSON & JOHNSON SEEKS U.S. FDA APPROVAL FOR CAPLYTA IN BIPOLAR MANIA, MARKING FIFTH POTENTIAL INDI
01:02:14 PM UTC
SquawkNews
Two positive Phase 3 studies showed CAPLYTA significantly reduced manic symptoms versus placebo as e
01:22:21 PM UTC
SquawkNews
BRIEF-Johnson & Johnson Seeks U.S. FDA Approval For Caplyta In Bipolar Mania, Marking Fifth Potentia